Table 1. Summary of HPV Integration Sites.
| Sample ID | Histology | HPV type | Integration locus | Gene | Fragile site involved |
| CT 712 | SCC | 16 | 1p36.12 | ALPQTL2 | FRA1A(1p36) com |
| CT 700 | SCC | 16 | 1p36.23 | - | FRA1A(1p36) com |
| CT 702 | SCC | 16 | 1p36.23 | - | FRA1A(1p36) com |
| CT 709 | SCC | 16 | 1p36.23 | - | FRA1A(1p36) com |
| CT 1138 | SCC | 16 | 1p36.33 | - | FRA1A(1p36) com |
| CT 809 | SCC | 16 | 1p36.33 | - | FRA1A(1p36) com |
| CT 866 | SCC | 16 | 1p36.33 | - | FRA1A(1p36) com |
| CT 864 | SCC | 16 | 1q42.13 | ABCB10 | FRA1H(1q42) com |
| CT 755 | SCC | 16 | 3q23 | SLC25A36 | - |
| CT 785 | SCC | 16 | 3q23 | SLC25A36 | - |
| 20q11.21 | COX4I2 | - | |||
| 18 | - | - | - | ||
| CT 1210 | SCC | 16 | 3q26.2 and Episomal | MECOM | - |
| CT 723 | SCC | 16 | 3q26.31 | - | FRA3C(3q27) com |
| CT 706 | SCC | 16 | 3q26.33 | SOX2 | FRA3C(3q27) com |
| CT 892 | SCC | 16 | 3q26.33 | - | FRA3C(3q27) com |
| CT 711 | SCC | 16 | 3q28 and Episomal | LEPREL1 | FRA3C(3q27) com |
| CT 739 | SCC | 16 | 3q28 | TP63 | FRA3C(3q27) com |
| CT 999 | SCC | 16 | 4q13.3 | IL8(∼3kb) | - |
| CT 1114 | SCC | 16 | 4q21.22 | HNRPDL | - |
| CT 893 | SCC | 16 | 6q22.31 | - | - |
| CT 1117 | AC | 16 | 6q22.31 | - | - |
| 18 | - | - | - | ||
| CT 1122 | SCC | 16 | 6q23.3 | PDE7B | - |
| CT 846 | SCC | 16 | 6q23.3 | MAP3K | - |
| CT 1019 | SCC | 16 | 7q11.21 | TYW1 | FRA7J(7q11) com |
| CT 796 | SCC | 16 | 8p11.21 | - | - |
| CT 915 | SCC | 16 | 8p11.21 | - | - |
| 18 | - | - | - |
Key: – SCC: Squamous cell carcinoma, AC: Adenocarcinoma, Com: Common Fragile site